Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,982.40
(
0.43%
)
Dow Jones
49,442.56
(
-0.01%
)
Brent Oil
91.35
(
0.74%
)
Bitcoin
76,728.36
(
1.10%
)
News Focus
News Focus
Post# of 44697
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

nelskof

Send PM Follow Ignore
Followers 15
Posts 1282
Boards Moderated 0
Alias Born 04/23/2020

nelskof

Re: JTORENCE post# 24190

Wednesday, 09/30/2020 3:40:43 PM

Wednesday, September 30, 2020 3:40:43 PM

Post# of 44697
It's 102 patients. "INTERIM" review in 28 days and 4 things can happen then.

1. Stop trial due to safety issues
2. Stop trial due to lack of efficacy
3. Continue trial (144 patients) DMC believes they can reach end points
4. Stop trial because efficacy has been demonstrated, it would be unethical to continue with placebo

All of us, including Dr Javitt, are rooting for #4. We were rooting for it end of August/beginning of September. I didn't think I would be rooting for it again, lol. At the end of today's video JJ showed excitement discussing this.

PROUD MEMBER OF THE WHALES HAIRY BACK CLUB

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent RLFTF News
More RLFTF News